Flunitrazepam



Indications and Reactions:

Role Indications Reactions
Primary
Overdose 32.1%
Suicide Attempt 32.1%
Convulsion Prophylaxis 10.7%
Drug Dependence 7.1%
Hiv Infection 7.1%
Mental Disorder 7.1%
Drug Use For Unknown Indication 3.6%
Nystagmus 40.0%
Pneumonia Aspiration 40.0%
Overdose 20.0%
Secondary
Product Used For Unknown Indication 16.4%
Insomnia 13.5%
Drug Use For Unknown Indication 13.1%
Depression 10.5%
Drug Abuse 9.2%
Anxiety 5.4%
Feeling Abnormal 4.6%
Frustration 4.6%
Self Injurious Behaviour 4.6%
Schizophrenia 3.6%
Schizophrenia, Paranoid Type 2.5%
Epilepsy 2.0%
Suicide Attempt 1.7%
Constipation 1.5%
Overdose 1.5%
Intentional Overdose 1.3%
Foetal Exposure During Pregnancy 1.2%
Exposure During Breast Feeding 0.9%
Restlessness 0.9%
Dysthymic Disorder 0.8%
Overdose 14.9%
Suicide Attempt 12.2%
Rhabdomyolysis 11.2%
Toxicity To Various Agents 7.4%
Urine Colour Abnormal 6.9%
Neuroleptic Malignant Syndrome 5.3%
Somnolence 5.3%
Pulmonary Embolism 4.8%
Ventricular Tachycardia 4.8%
Constipation 3.2%
Hyperphagia 3.2%
Tremor 3.2%
Sudden Death 2.7%
Death 2.1%
Multiple Drug Overdose 2.1%
Pneumonia Aspiration 2.1%
Restlessness 2.1%
Sepsis 2.1%
Tachycardia 2.1%
Treatment Noncompliance 2.1%
Concomitant
Schizophrenia 18.8%
Insomnia 12.0%
Depression 10.7%
Product Used For Unknown Indication 10.5%
Drug Use For Unknown Indication 9.1%
Constipation 5.4%
Schizophrenia, Paranoid Type 5.1%
Prophylaxis 4.6%
Hiv Infection 3.7%
Hypertension 2.5%
Bipolar Disorder 2.3%
Schizophrenia, Disorganised Type 2.3%
Pruritus 2.2%
Rheumatoid Arthritis 1.9%
Gastroenteritis 1.6%
Nasopharyngitis 1.6%
Gastric Cancer 1.5%
Pain 1.5%
Gastritis 1.4%
Anxiety 1.4%
Vomiting 7.6%
Psychiatric Symptom 6.7%
Rhabdomyolysis 6.7%
Neuroleptic Malignant Syndrome 6.4%
Pyrexia 6.1%
Suicide Attempt 6.1%
Tremor 6.1%
White Blood Cell Count Increased 5.5%
Stevens-johnson Syndrome 5.2%
Water Intoxication 5.2%
Completed Suicide 4.9%
White Blood Cell Count Decreased 4.9%
Convulsion 4.6%
Ileus 4.3%
Liver Disorder 4.0%
Malaise 3.6%
Insomnia 3.3%
Neuroendocrine Tumour 3.0%
Pneumonia 3.0%
Pneumonia Aspiration 3.0%
Interacting
Drug Use For Unknown Indication 72.7%
Intentional Overdose 18.2%
Alveolar Soft Part Sarcoma 3.0%
Malignant Soft Tissue Neoplasm 3.0%
Restlessness 3.0%
Drug Toxicity 50.0%
Drug Interaction 12.5%
Long Qt Syndrome 12.5%
Speech Disorder 12.5%
Tachycardia 12.5%